Who Paid My Doc
Prevnar 20
Biological Vaccines
NDC 0005-2000-10
General payments
$404,364
Research payments
$21,582,187
Through program year 2021, $404,364 in general payments and $21,582,187 in research payments were reported against Prevnar 20 (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $404,364 | 16,558 |
| 2021 | Research | $21,582,187 | 4,968 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 92 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
16,558 general · 4,968 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.